Boehringer Ingelheim Animal Health USA Inc.
Duluth, GA Doing business as Boehringer Ingelheim Vetmedica Inc.
- UEI
- N8ZHMK52HNG9
- CAGE
- 50614
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3239 Satellite Blvd, Duluth, GA 30096, USA
- Website
- boehringer-ingelheim.com
- Founded
- 1885
- Employees
- 50K-100K
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Raboral VRG raccoon baits, coated sachets, 128370 | Marketing and Regulatory Programs Business Services | $3,154,050 | |
| Delivery order for oral rabies vaccine (ORV) baits | Marketing and Regulatory Programs Business Services | $3,529,053 | |
| Delivery order for oral rabies vaccine (ORV) baits | Marketing and Regulatory Programs Business Services | $290,250 | |
| Delivery order of oral rabies vaccine (ORV) baits | Marketing and Regulatory Programs Business Services | $645,129 | |
| Delivery order for oral rabies vaccine (ORV) baits | Marketing and Regulatory Programs Business Services | $3,938,515 |
About Boehringer Ingelheim Animal Health USA Inc.
Boehringer Ingelheim Animal Health USA Inc., doing business as Boehringer Ingelheim Vetmedica Inc., manufactures and supplies oral rabies vaccine (ORV) baits to the federal government as a prime contractor, holding exclusive manufacturing rights to RABORAL V-RG, the sole licensed ORV bait product available in the United States. The company competes on a full-and-open, sole-source basis across all recent awards, holding no SBA set-aside certifications. Boehringer Ingelheim is a for-profit manufacturer of veterinary biologicals headquartered in Duluth, Georgia, where it operates the manufacturing facility supporting all federal deliveries.
The vendor's federal portfolio is heavily concentrated with the Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) Wildlife Services program, which accounts for 35 of 46 total awards and $86.4 million of the $102.4 million combined potential value across the portfolio — 84% of all dollars. APHIS Wildlife Services uses ORV baits to control and eliminate rabies in wildlife populations across multiple states as part of its core mission. Secondary customers include APHIS Marketing and Regulatory Programs Business Services (3 awards, $15.1 million), the Department of Homeland Security Science and Technology Directorate ($916 thousand), the Defense Logistics Agency Troop Support Medical ($8 thousand across 5 awards), and the National Oceanic and Atmospheric Administration ($5 thousand). A cooperative agreement recipient role with the USDA Agricultural Research Service extends through August 2026, supporting development of short-term experiential learning opportunities for students pursuing DVM and Ph.D. degrees in animal health research.
The vendor holds five active indefinite delivery contracts with APHIS Wildlife Services, each structured as single-award vehicles with Boehringer Ingelheim as the sole source. The largest, awarded June 2024, carries a $14.413 million ceiling extending through June 2027 and has generated 8 delivery orders to date. Four predecessor IDCs — valued at $9.945 million, $9.9 million, $8.3 million, and $6.6 million respectively — supported 23 delivery orders from 2021 through 2024. Individual delivery orders range from roughly $191 thousand to $4.1 million, issued as firm fixed-price purchase orders and delivery orders for coated sachet (RABORAL V-RG raccoon baits, formulation 128370) and fishmeal polymer baits (formulation 128425) in quantities measured in lots of 300 units. Work is performed in Duluth, Georgia. The source data reflects activity declining from peak years (6 awards in 2024, 5 in 2023) to 4 awards in 2025 and 1 in 2026; only one award ($3.529 million, completion August 2026) reaches completion within the next twenty-four months, creating minimal near-term recompete exposure. All federal work is conducted as prime awards with no subcontractor footprint recorded in the source data.
Quick answers
What is Boehringer Ingelheim Animal Health USA Inc.'s UEI?
Boehringer Ingelheim Animal Health USA Inc.'s Unique Entity ID (UEI) in SAM.gov is N8ZHMK52HNG9.
What is Boehringer Ingelheim Animal Health USA Inc.'s CAGE code?
Boehringer Ingelheim Animal Health USA Inc.'s CAGE code is 50614.
What is Boehringer Ingelheim Animal Health USA Inc.'s primary NAICS code?
Boehringer Ingelheim Animal Health USA Inc.'s primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Boehringer Ingelheim Animal Health USA Inc. located?
Boehringer Ingelheim Animal Health USA Inc.'s physical address in SAM.gov is 3239 Satellite Blvd, Duluth, GA 30096, USA.
Is Boehringer Ingelheim Animal Health USA Inc. registered in SAM.gov?
Yes. Boehringer Ingelheim Animal Health USA Inc.'s SAM.gov registration is active through January 13, 2027.
What is Boehringer Ingelheim Animal Health USA Inc.'s most recent federal award?
Boehringer Ingelheim Animal Health USA Inc.'s most recent federal contract award is Raboral VRG raccoon baits, coated sachets, 128370 (12639526F0890), from Marketing and Regulatory Programs Business Services, on September 17, 2026.
On GovTribe
See Boehringer Ingelheim Animal Health USA Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors